moclobemide has been researched along with Chemical Dependence in 4 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Serotonin syndrome is a potentially life-threatening complication of psychopharmacological drug therapy." | 2.40 | Serotonin syndrome and drug combinations: focus on MAOI and RIMA. ( Hilton, SE; Maradit, H; Möller, HJ, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hung, CC | 1 |
| Lee, CH | 1 |
| Ko, AM | 1 |
| Lane, HY | 1 |
| Lee, CP | 1 |
| Ko, YC | 1 |
| Hilton, SE | 1 |
| Maradit, H | 1 |
| Möller, HJ | 1 |
| Montgomery, SA | 1 |
| Wesnes, K | 1 |
| Anand, R | 1 |
| Lorscheid, T | 1 |
2 reviews available for moclobemide and Chemical Dependence
| Article | Year |
|---|---|
Serotonin syndrome and drug combinations: focus on MAOI and RIMA.
Topics: Autonomic Nervous System Diseases; Benzamides; Brain Stem; Drug Therapy, Combination; Humans; Moclob | 1997 |
Social phobia: diagnosis, severity and implications for treatment.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Behavior Therapy; Benzamides; Benzodiazepines; Child | 1999 |
2 trials available for moclobemide and Chemical Dependence
| Article | Year |
|---|---|
Effect of antidepressants for cessation therapy in betel-quid use disorder: a randomised, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Areca; Asian People; Citalopram; Double-Blind Method | 2020 |
Potential of moclobemide to improve cerebral insufficiency identified using a scopolamine model of aging and dementia.
Topics: Adult; Alzheimer Disease; Antidepressive Agents; Attention; Benzamides; Cognition; Dose-Response Rel | 1990 |